
Elidel: A steroid-free anti-inflammatory cream for eczema. It calms the immune reaction in the skin without thinning it, which is why it is used on the face, eyelids and skin folds. Eucrisa: A non-steroid ointment for mild to moderate eczema. It can be used on the face and in skin folds, and there is no limit on how long it can be used.


Choose for eczema on delicate skin — face, eyelids, folds — when you want to avoid steroid thinning.
Choose for mild to moderate eczema when you want a non-steroid you can use anywhere, for as long as needed.
Can you take them together?
Both are steroid-free eczema creams for sensitive areas. Most people use one or the other.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.









Inhibits calcineurin: Blocks a switch that helps activate T cells. Reduces immune messengers: T cells release fewer inflammation-driving signals. Calms eczema and itch: Redness and irritation ease as inflammation settles.
The drug binds FKBP-12 and inhibits calcineurin, reducing T-cell cytokine transcription; the complete atopic-dermatitis mechanism is not known. It also has other cellular effects.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Eczema redness and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
When to Apply: A thin layer twice a day on the affected skin. Rub it in until it disappears. Moisturizer can go on top or underneath.
How to Start: Twice daily as soon as a flare starts, and keep going until the skin is clear rather than merely better. Many people then move to two or three days a week on the spots that always come back, to head off the next flare. Discuss that with your doctor.
If It Irritates: Warmth, stinging or burning for the first few days is the commonest complaint. It happens because the skin is inflamed, not because you are allergic, and it usually stops within a week as the eczema settles. Keeping the cream in the fridge, moisturizing first, or starting once a day for a few days makes it easier.
If It's Not Working: Nothing to increase — there is one strength. Give it six weeks of consistent twice-daily use. If the skin is no better, the usual next steps are a short steroid course to reset it, a switch to tacrolimus ointment, or a newer non-steroid cream.
When to Apply: A thin layer twice a day on the inflamed areas, on clean dry skin. Moisturizer goes everywhere, including over the top once it has settled.
How to Start: Twice daily from day one, on the flaring areas only, not over the whole body as a preventive. If the stinging is hard to tolerate, moisturize first and use the ointment straight from the fridge. The stinging usually fades within the first week.
If It Irritates: Burning or stinging for a few minutes after applying is the commonest effect, and usually not an allergy. It settles as the skin heals. Redness spreading beyond where you applied it, or stinging that gets worse rather than better after two weeks, should be reviewed.
If It's Not Working: There is one strength, so there is nothing to increase. Four weeks of proper twice-daily use is a fair trial. After that: a different non-steroid, a short steroid course to break the flare, or a look at what else is driving the rash.
No routine blood tests. Blood levels are very low or undetectable, and it does not affect the adrenal glands the way strong steroids do.
Monitoring is a conversation at six weeks, then longer intervals if you stay on it. Your doctor is checking whether the eczema is actually controlled, whether steroid rescue courses have been needed often enough to suggest a change of plan, and whether any patch of skin is behaving oddly rather than simply eczema.
Because of the boxed warning, most dermatologists look harder at any new or changing spot in long-term users rather than assuming it is part of the rash. Registry follow-up has not found the increase in skin cancer or lymphoma the warning anticipated, so this is ordinary caution, not surveillance for a known risk.
No blood tests and no routine monitoring. Very little reaches the bloodstream, and what does is broken down quickly, so nothing accumulates.
Monitoring is a review at about four weeks to decide whether it is working. Long term, this is a drug people can stay on: no maximum duration, no limit on the area treated, no rest period. That is the practical difference between it and a topical steroid.
The one thing worth watching is whether it is quietly standing in for treatment that would actually control the disease. Eczema that keeps escaping it needs a different plan, not more months of the same ointment.
Approximate windows, not promises.
First few minutesApplying it: A thin layer twice a day. Warmth or stinging for a few minutes, strongest on the rawest skin.
First few minutesApplying it: A thin layer twice a day. Stinging or warmth for a few minutes is common, worst in week one.
Days 1 to 5Adjusting: The stinging is at its worst now and fades as the skin heals. Itch often eases while the rash looks the same.
Weeks 1 to 2Working: Redness fades, skin feels less tight. Night scratching drops off first.
Weeks 2 to 6Judge it here: The rash flattens and clears. The fair point to decide whether it is doing enough.
Face, eyelids and foldsIts strongest use: Thin skin is where steroids cause the most trouble, so a non-thinning option is worth losing some strength. Armpits, groin and under the breasts thin quickly too.
OngoingHolding: Once clear, many drop to two or three applications a week on the areas that always flare. No thinning means no time limit.
OngoingFace, eyelids and folds: Its strongest case. Use it on and off as needed: no cumulative limit, no rest period, none of the thinning that limits steroids on thin skin.
Days 1 to 7Adjusting: Stinging is at its worst now. Itch eases before the rash looks different.
Week 2Settling: Redness and scaling fade. Most of the stinging has gone.
Week 4Judge it here: The point the trials measured. A meaningful share of people reach clear or almost clear skin; a meaningful share do not. No change by four weeks means more time will not help.
Sorted by what to do about them.
Cost has improved. Generic pimecrolimus cream brought the price down from one of the more expensive eczema treatments to something ordinary. Brand-name Elidel is still costly.
The usual obstacle is not price but step therapy. Because the label calls it second-line, many plans want to see that a topical steroid was tried and failed, or a reason a steroid should not be used, before covering it. A note from your doctor saying the eczema is on the eyelids or in the folds usually settles that.
Cash prices for the generic vary between pharmacies more than most drugs, so check a discount card price before assuming you cannot afford it. Tube size matters too — a large tube is often better value per gram, and eczema treatment runs longer than people expect.
Cost is the obstacle here, not safety. It has been brand-name with no stocked generic for most of its life, and the cash price for a large tube is high. Generic availability changes, so ask the pharmacy.
Prior authorization is common. Plans usually want a topical steroid first, sometimes a calcineurin inhibitor too, which is cheaper as a generic. A savings card exists for people with commercial insurance, with terms that change often.
Tube size matters more than with most creams, because it goes on twice a day over an area. A small tube covering a child's whole body lasts days. Ask for the size that matches the area treated.
No. Different pathway, and it does not thin the skin — the whole reason it is used on eyelids, the face and skin folds.
Because at approval regulators noted that related medicines suppress immunity body-wide in transplant patients, that very high oral doses caused tumors in animals, and that a small number of cancer reports existed in users. The warning states that long-term safety is not established — a precaution, not a finding. Follow-up since has not shown an increased rate of skin cancer or lymphoma.
Because the skin underneath is inflamed. It is the commonest side effect, strongest in the first few days, and it settles as the eczema heals. Moisturizing first or chilling the tube helps.
No fixed limit. It does not thin skin, so it can run in repeated courses, or two or three times a week, for years with review.
Yes — eyelids are one of its main uses, one of the few anti-inflammatory options that can go there repeatedly without thinning skin or raising eye pressure.
No. Tacrolimus 0.1% ointment is more powerful for moderate eczema. Pimecrolimus is better tolerated and cosmetically easier, so it is often the one people keep using.
Probably the drug itself acting on inflamed skin, not the base. It is the commonest complaint, worst in the first days, and fades within a week.
Thin skin is where it makes the most sense and it is used there, but not in the eye itself. Keep it off the lid margin.
No, it is milder. Its advantage is delicate skin and long stretches without the thinning that limits steroids.
There is no set limit. On during flares, off in between, for as long as it helps.
It is licensed from three months of age.
Licensed for atopic dermatitis. Doctors sometimes use it off-label for other inflammatory rashes, where the evidence is thinner.